SlideShare ist ein Scribd-Unternehmen logo
1 von 6
Downloaden Sie, um offline zu lesen
www.bio-banking-event.com
Register online or fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711
@SMIPHARM
#BioBankingSMi
CHAIRS:
•	Emma Snapes, Biobank Manager, Infant Biobank
•	Dr Brian Thomson, Director and Clinical Lead for 100K Genome
Project, Nottingham Health Science Biobank
KEYNOTE SPEAKERS INCLUDE:
•	Professor Glyn Stacey, Director, UK Stem Cell Bank, Division of
Advanced Therapies, National Institute for Biological Standards and
Control - MHRA
• Octavi Quintana Trias, Principal Advisor of DG, European Commission
• Dr Julia Riedlinger, Head of Marker Scouting and Sample Bank,
Roche Diagnostics
• Arthur Lewis, Senior R&D Manager, MedImmune
• Dr Michael Luntang-Jensen, Biobank Manager, H. Lundbeck A/S
• Jonathan Sellors, Legal Counsel, UK Biobank
BENEFITS OF ATTENDING IN 2016:
•	Spotlight session - Creating a
biobank for drug discovery
• Hear the latest updates on Data
Protection Act from European
Commission and UK Biobank
• Learn about the integration of
biobanking in drug development
• Obtain an overview of how to
build and design a model of next
generation biobank
• Discover the latest updates on
biobanking in the 21st Century
20TH-21ST
JUNE
2016HOLIDAY INN KENSINGTON FORUM, LONDON, UK
SMi presents the 6th annual…
BioBankingEnsuring compliance through regulatory updates and
its impact on biobanking
BOOK BY 31ST MARCH TO SAVE £400 • BOOK BY 29TH APRIL TO SAVE £300 • BOOK BY 27TH MAY 2016 AND SAVE £200
HEAR FROM MHRA,
EUROPEAN COMMISSION
PLUS LEADING EUROPEAN BIOBANKS!
BioBanking
Day One | 20th June 2016 	 www.bio-banking-event.com
8.30	 Registration & Coffee
9.00	 Chairman’s Opening Remarks
Emma Snapes, Biobank Manager, Infant Biobank
	 OPENING ADDRESS
9.10	 Biobanking in the 21st century: Where are we now?
•	Public engagement
•	Ethics and regulatory issues
•	Sustainability
•	Harmonisation
Emma Snapes, Biobank Manager, Infant Biobank
KEYNOTE ADDRESS
9.50	 Assuring long term supply chain of stem cells for future 		
	therapies
•	The key issues relating to the cryo-conservation of stem
cell cultures of human pluripotent stem cell lines are
significant loss of viable cells during preservation and
recovery, reproducibility and reliability of recovery
from preservation and assuring appropriate storage
quarantine procedures
•	Establishing appropriate systems to ensure stable
storage temperatures and suitable testing regimes for
viability and recovery testing regimes are essential for
operation of successful stem cell biobanks
•	Requalification of stem cell banks over the long term will
need to be considered, based on developing scientific
knowledge and emerging issues
Prof Glyn Stacey, Director, UK Stem Cell Bank, Division
of Advanced Therapies, National Institute for Biological
Standards and Control – MHRA
10.30 	 Morning Coffee
BIOBANKING AS A BUSINESS
11.00	 Auria Biobank – model for next generation biobanking
•	What does next generation biobanking mean?
•	Gain insight to the rewards of innovative biobanking
•	Sustainability by Public-Private Partnership and new
co-operation models
Heli Salminen-Mankonen, Director, Auria Biobank
11.40	 Designing a modern biobank
•	Formation of a biobank
•	Ethical and legal issues
•	Developing a sustainable business model
•	Personalised medicine vs general medicine
•	Maximising value thought publicity
Dr. Balwir Matharoo-Ball, Deputy Director of Nottingham
Health Science Biobank, Nottingham University Hospital
NHS Trust
12.20	 Networking Lunch
THE POWER OF SAMPLES
1.30	 Biomarker identification and validation – the crucial role 		
	 of samples
•	Challenges of biomarker discovery and validation
•	Access to well-characterised samples
•	Sample and data quality
•	Ethical considerations
Dr Julia Riedlinger, Head of Marker Scouting and Sample
Bank, Roche Diagnostics
2.10	 Optimising clinical laboratory sample usage
•	Focus on Science to maximise the use of every sample
•	Adapt to legislation changes
•	Optimising sample collection and analysis
Dr Catherine Mela, Director Clinical Sample Science,
AstraZeneca
2.50	 Afternoon Tea
3.20	 Human tissue driving biologics research
•	Why is human tissue important - selecting relevant
therapeutic targets
•	How is human tissue used for and how can bio banks
work with biopharma
•	What is human tissue delivering to biologics research
Dr Arthur Lewis, Senior R&D Manager, MedImmune
4.00	 Impact of brain bio-banking on Parkinson’s disease 		
	research
•	Shedding light on disease mechanisms
•	Identification of drug targets
•	Neuropathological confirmation of clinical diagnosis
Prof David Dexter, Director of Parkinson’s UK Tissue Bank,
Imperial College London
4.40	 Chairman’s Closing Remarks and Close of Day One
Register online at www.bio-banking-event.com
SUPPORTED BY
SPONSORSHIP AND EXHIBITION OPPORTUNITIES
SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to complement your company’s marketing strategy. Prime
networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your
industry. Should you wish to join the increasing number of companies benefiting from sponsoring our conferences please call:
Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk
OFFICIAL MEDIA PARTNERS OFFICIAL PUBLICATIONS
BioBanking
www.bio-banking-event.com	 Day Two | 21st June 2016
8.30	 Registration & Coffee
9.00	 Chairman’s Opening Remarks
Dr Brian Thomson, Director and Clinical Lead for 100K
Genome Project, Nottingham Health Science Biobank
ETHICAL AND REGULATORY LANDSCAPE
KEYNOTE OPENING ADDRESS
9.10	 Data Protection Act
•	Revision of the latest changes
•	The effect on local projects
•	Ethical dilemma when sharing biobank data
•	Regulation and sustainability of biobanking in general
Octavi Quintana Trias, Principal Advisor of DG,
European Commission
9.50	 Use of research data
•	The use of pseudo-anonymised participant data in
research, and common misunderstandings relating
to such use in the application of the law on data
protection and confidentiality
•	Linkage between research data sets – common
problems (and misunderstandings)
•	The prevailing legal framework in the UK and how this
will be impacted by the EU Data Protection Regulation
Jonathan Sellors, Legal Counsel, UK Biobank
10.30 	 Morning Coffee
HARMONISATION IN BIOBANKING
11.00	 European Bank for induced Pluripotent Stem Cells (EBiSC): 	
	 Creating a biobank for stem cells
•	Why induced Pluripotent Stem Cells (iPSCs) represent an
important new research tool
•	How the (EBiSC) acts as a central repository for iPSC lines
created across Europe
•	The challenges encountered in building the bank
Aidan Courtney, Chief Executive Officer,
Roslin Cell Sciences Ltd
11.40	 European Bank for induced Pluripotent Stem Cells (EBiSC): 	
	 International distribution and long-term sustainability
•	Challenges of international distribution of cell lines
•	Creating and satisfying end user demand
•	Factors influencing long-term sustainability of biobanks
Dr Bryan Bolton, Head of Business Development, Culture
Collection, Public Health England
12.20	 Networking Lunch
1.30	 Biobanking and genomic research in clinical trials:
	 Challenges and solutions in working with global health 		
	 authorities and IRB/IECs
•	Discuss Merck’s clinical pharmacogenomic and
biobanking strategy
•	Understand challenges in biobanking and conducting
genomic research in the context of global clinical trials
•	Discuss strategies and solutions to manage requirements
from global health authorities and IRB/IECs
Dr Karina Bienfait, Head, Global Genomics Policy, Process
and Compliance, MSD
2.10	 Integration of biobanking in drug development
•	Organizational and logistic requirements for high quality
sample management
•	Ethical and regulatory challenges
•	Management responsibility and governance
Dr Michael Luntang-Jensen, Biobank Manager,
H. Lundbeck A/S
2.50	 Afternoon Tea
3.20	 Creating a UK biobanking network; the human and 		
	 technological challenges
•	Biobanking in the UK - the need for transformation
•	Realising the value of biobanks as platforms for precision
medicine
•	The purpose of the UKCRC Directory
•	How the Directory fits into the European programme
•	The future - standardisation
Dr Brian Thomson, Director and Clinical Lead for 100K
Genome Project, Nottingham Health Science Biobank
Dr Phil Quinlan, Interim Director, UKCRC Tissue Directory
and Co-ordination Centre, University of Nottingham
4.00	 The CCLG tissue bank: Experience from a national 		
	 children’s tumour bank
Dr Thomas Jacques, Chair CCLG Biological Studies
Steering Group, University College London
4.40	 Chairman’s Closing Remarks and Close of Day Two
Alternatively fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711
SUPPORTED BY
Want to know how you can get involved? Interested in promoting your services to this market?
Contact Honey de Gracia, SMi Marketing on
+44 (0)20 7827 6102 or email: hdegracia@smi-online.co.uk
SPOTLIGHT
SESSION
Benefits of Sponsoring
Biobanking 2016
The industry has reached a tipping point
and is about to enter the commercial stage.
With lots of exciting opportunities ahead of
biobanks, join our 6th annual Biobanking
meeting to:
1. 	Showcase your biobanking services and
products through keynote presentation
to senior decision makers to help them
overcome commercial challenges
2. 	Leverage your brand and exposure by
exhibiting
3. 	Meet and network with senior decision
makers – understand their priorities and
how their businesses are developing
4. 	Engage with your prospects and foster
growth with existing clients during our
quality networking breaks
5. 	Ensure your service and product offerings
fit with the industry’s today needs, and
benefit from our tailored sponsorship
packages
For further information, please contact 	
Alia Malick, Director, on +44 (0) 20 7827 6168
or email: amalick@smi-online.co.uk
Past Years’ Attendees
Profile by Sector
Register online at
www.bio-banking-event.com
Pharma & Biotech	 59.5%
Academia	16.2%
Consultancy 	 13.5%
Regulatory	10.8%
59.5%
13.5%
10.8%
16.2%
SMi PHARMACEUTICAL
EVENT PLANNER 2016
MARCH
Superbugs & Superdrugs - A Focus on Antibacterials
16th - 17th March
Holiday Inn Kensington Forum, London, UK
Paediatric Clinical Trials
16th - 17th March
Holiday Inn Kensington Forum, London, UK
APRIL
Asthma & COPD
11th - 12th April
Holiday Inn Kensington Forum, London, UK
Controlled Release
18th - 19th April
Holiday Inn Kensington Forum, London, UK
Adaptive Designs
18th - 19th April
Holiday Inn Kensington Forum, London, UK
Pre-Filled Syringes East Coast
25th - 26th April
Renaissance Woodbridge, New Jersey, USA
Lyophilization USA
27th - 28th April
Renaissance Woodbridge, New Jersey, USA
MAY
Alzheimer’s
10th - 11th May
Holiday Inn Kensington Forum, London, UK
Clinical Trial Logistics
18th - 19th May
Holiday Inn Kensington Forum, London, UK
Pain Therapeutics
23rd - 24th May
Holiday Inn Kensington Forum, London, UK
ADC Summit 2016
23rd - 24th May
Holiday Inn Kensington Forum, London, UK
JUNE
Pre-Filled Syringes West Coast
6th - 7th June
Hyatt Regency Mission Bay, San Diego, USA
ADMET
13th - 14th June
Holiday Inn Kensington Forum, London, UK
Immunogenicity
13th - 14th June
Holiday Inn Kensington Forum, London, UK
BioBanking
20th - 21st June
Holiday Inn Kensington Forum, London, UK
JULY
Lyophilisation Europe
4th - 5th July
Holiday Inn Kensington Forum, London, UK
Allergies
6th - 7th July
Holiday Inn Kensington Forum, London, UK
Peptides
6th - 7th July
Holiday Inn Kensington Forum, London, UK
Please complete fully and clearly in capital letters. Please photocopy for additional delegates.
Title:	Forename:
Surname:
Job Title:
Department/Division:
Company/Organisation:
Email:
Company VAT Number:
Address:
Town/City:	
Post/Zip Code:	 Country: 	
Direct Tel:		 Direct Fax:
Mobile:	
Switchboard:
Signature: 			 Date:
I agree to be bound by SMi’s Terms and Conditions of Booking.
ACCOUNTS DEPT
Title:	Forename:
Surname:
Email:
Address (if different from above):
Town/City:	
Post/Zip Code:	 Country: 	
Direct Tel:		 Direct Fax: 		
BIOBANKING
Conference: 20th - 21st June 2016, Holiday Inn Kensington Forum, London, UK
4 WAYS TO REGISTER
FAX your booking form to +44 (0) 870 9090 712
PHONE on +44 (0) 870 9090 711
ONLINE at www.bio-banking-event.com
POST your booking form to: Events Team, SMi Group Ltd, 2nd Floor South, Harling House,
47-51 Great Suffolk Street, London, SE1 0BS
If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email them at events@smi-online.co.uk
Payment: If payment is not made at the time of booking, then an invoice will be issued and must
be paid immediately and prior to the start of the event. If payment has not been received then
credit card details will be requested and payment taken before entry to the event. Bookings within
7 days of event require payment on booking. Access to the Document Portal will not be given until
payment has been received.
Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another
delegate to take your place at any time prior to the start of the event. Two or more delegates may
not ‘share’ a place at an event. Please make separate bookings for each delegate.
Cancellation: If you wish to cancel your attendance at an event and you are unable to send
a substitute, then we will refund/credit 50% of the due fee less a £50 administration charge,
providing that cancellation is made in writing and received at least 28 days prior to the start of the
event. Regretfully cancellation after this time cannot be accepted. We will however provide the
conferences documentation via the Document Portal to any delegate who has paid but is unable
to attend for any reason. Due to the interactive nature of the Briefings we are not normally able to
provide documentation in these circumstances. We cannot accept cancellations of orders placed
for Documentation or the Document Portal as these are reproduced specifically to order. If we
have to cancel the event for any reason, then we will make a full refund immediately, but disclaim
any further liability.
Alterations: It may become necessary for us to make alterations to the content, speakers, timing,
venue or date of the event compared to the advertised programme.
Data Protection: The SMi Group gathers personal data in accordance with the UK Data Protection
Act 1998 and we may use this to contact you by telephone, fax, post or email to tell you about
other products and services. Unless you tick here □ we may also share your data with third parties
offering complementary products or services. If you have any queries or want to update any of the
data that we hold then please contact our Database Manager databasemanager@smi-online.
co.uk or visit our website www.smi-online.co.uk/updates quoting the URN as detailed above your
address on the attached letter.
Unique Reference Number 	
Our Reference		 P-174
Terms and Conditions of Booking
DELEGATE DETAILS
Payment must be made to SMi Group Ltd, and received before the event,
by one of the following methods quoting reference P-174 and the delegate’s
name. Bookings made within 7 days of the event require payment on booking,
methods of payment are below. Please indicate method of payment:
□ UK BACS	 Sort Code 300009, Account 00936418
□ Wire Transfer	 Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AU
		 Swift (BIC): LOYDGB21013, Account 00936418
		 IBAN GB48 LOYD 3000 0900 9364 18
□ Cheque	 We can only accept Sterling cheques drawn on a UK bank.
□ Credit Card 	 □ Visa □ MasterCard □ American Express
	 All credit card payments will be subject to standard credit card charges.
Card No: □□□□ □□□□ □□□□ □□□□
Valid From □□/□□ 	 Expiry Date □□/□□
CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card
Cardholder’s Name:
Signature: 				Date:
I agree to be bound by SMi’s Terms and Conditions of Booking.
Card Billing Address (If different from above):
DOCUMENTATION
I cannot attend but would like to Purchase access to the following Document Portal/
Paper Copy documentation.	 Price 		 Total
□	Access to the conference documentation
on the Document Portal 	 £499.00 	 + VAT 	 £598.80
□	The Conference Presentations – paper copy 	 £499.00 	 - 	 £499.00
(or only £300 if ordered with the Document Portal)
PAYMENT
VAT
VAT at 20% is charged on the attendance fees for all delegates. VAT is also charged
on Document portal and literature distribution for all UK customers and for those EU
Customers not supplying a registration number for their own country here
CONFERENCE PRICES	 GROUP DISCOUNTS AVAILABLE
I would like to attend: (Please tick as appropriate)	Fee		 TOTAL
□	 Conference 	 £1499.00 	 + VAT 	 £1798.80
PROMOTIONAL LITERATURE DISTRIBUTION
□	 Distribution of your company’s promotional
	 literature to all conference attendees 	 £999.00	 + VAT	 £1198.80	
The conference fee includes refreshments, lunch, conference papers, and
access to the Document Portal. Presentations that are available for download
will be subject to distribution rights by speakers. Please note that some
presentations may not be available for download. Access information for the
document portal will be sent to the e-mail address provided during registration.
Details are sent within 24 hours post conference.
VENUE Holiday Inn Kensington Forum, 97 Cromwell Road, London SW7 4DN
□ Please contact me to book my hotel
Alternatively call us on +44 (0) 870 9090 711,
email: events@smi-online.co.uk or fax +44 (0) 870 9090 712
□ Book by 31st March 2016 and save £400
□ Book by 29th April 2016 and save £300
□ Book by 27th May 2016 and save £200
EARLY BIRD
DISCOUNT

Weitere ähnliche Inhalte

Was ist angesagt?

Clinical Trial Accrual Challenges: Is Social Media Here to Help? (A. Denicoff)
Clinical Trial Accrual Challenges: Is Social Media Here to Help? (A. Denicoff)Clinical Trial Accrual Challenges: Is Social Media Here to Help? (A. Denicoff)
Clinical Trial Accrual Challenges: Is Social Media Here to Help? (A. Denicoff)Esmeralda Casas-Silva, Ph.D.
 
Arab Health Congress 2016 - Big Data Brochure
Arab Health Congress 2016 - Big Data Brochure Arab Health Congress 2016 - Big Data Brochure
Arab Health Congress 2016 - Big Data Brochure Cheryl Prior
 
Arab Health Congress 2016 - Gastroenterology Conference
Arab Health Congress 2016 - Gastroenterology ConferenceArab Health Congress 2016 - Gastroenterology Conference
Arab Health Congress 2016 - Gastroenterology ConferenceCheryl Prior
 
Panel on Access
Panel on AccessPanel on Access
Panel on Accessflasco_org
 
Outcome Measures in Cancer: Do disease specific instruments offer greater sen...
Outcome Measures in Cancer: Do disease specific instruments offer greater sen...Outcome Measures in Cancer: Do disease specific instruments offer greater sen...
Outcome Measures in Cancer: Do disease specific instruments offer greater sen...Office of Health Economics
 
2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical TrailsKaren Radley
 
Roadmap Molecular Diagnostics
Roadmap Molecular DiagnosticsRoadmap Molecular Diagnostics
Roadmap Molecular DiagnosticsEuroBioForum
 
Νικόλαος Τσούλος, MedTech Conference 2021
Νικόλαος Τσούλος, MedTech Conference 2021Νικόλαος Τσούλος, MedTech Conference 2021
Νικόλαος Τσούλος, MedTech Conference 2021Starttech Ventures
 
Making Value-Based Healthcare in Cataract a Reality Insights from VBHCAT Pr...
Making Value-Based Healthcare in Cataract a Reality  Insights from VBHCAT  Pr...Making Value-Based Healthcare in Cataract a Reality  Insights from VBHCAT  Pr...
Making Value-Based Healthcare in Cataract a Reality Insights from VBHCAT Pr...Alexandre Lourenço
 
Designing and implementing pathways to benefit patient aftercare: Continuing ...
Designing and implementing pathways to benefit patient aftercare: Continuing ...Designing and implementing pathways to benefit patient aftercare: Continuing ...
Designing and implementing pathways to benefit patient aftercare: Continuing ...NHS Improvement
 
Investor & Analyst Day 2015: Cologuard Expansion (2/8)
Investor & Analyst Day 2015: Cologuard Expansion (2/8)Investor & Analyst Day 2015: Cologuard Expansion (2/8)
Investor & Analyst Day 2015: Cologuard Expansion (2/8)Exact Sciences
 
SMi Group's 4th annual Orphan Drugs 2015 conference
SMi Group's 4th annual Orphan Drugs 2015 conferenceSMi Group's 4th annual Orphan Drugs 2015 conference
SMi Group's 4th annual Orphan Drugs 2015 conferenceDale Butler
 
Efficiency Awards Winners Brochure 2011
Efficiency Awards Winners Brochure 2011Efficiency Awards Winners Brochure 2011
Efficiency Awards Winners Brochure 2011Simon Pace
 
Next Generation Dx Summit 2015 - Moving Assays to the Clinic
Next Generation Dx Summit 2015 - Moving Assays to the ClinicNext Generation Dx Summit 2015 - Moving Assays to the Clinic
Next Generation Dx Summit 2015 - Moving Assays to the ClinicJames Prudhomme
 
CURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumCURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumMelanoma Research Foundation
 

Was ist angesagt? (20)

Clinical Trial Accrual Challenges: Is Social Media Here to Help? (A. Denicoff)
Clinical Trial Accrual Challenges: Is Social Media Here to Help? (A. Denicoff)Clinical Trial Accrual Challenges: Is Social Media Here to Help? (A. Denicoff)
Clinical Trial Accrual Challenges: Is Social Media Here to Help? (A. Denicoff)
 
Arab Health Congress 2016 - Big Data Brochure
Arab Health Congress 2016 - Big Data Brochure Arab Health Congress 2016 - Big Data Brochure
Arab Health Congress 2016 - Big Data Brochure
 
Arab Health Congress 2016 - Gastroenterology Conference
Arab Health Congress 2016 - Gastroenterology ConferenceArab Health Congress 2016 - Gastroenterology Conference
Arab Health Congress 2016 - Gastroenterology Conference
 
Cancer 2014: Why do we need a focus on value?
Cancer 2014: Why do we need a focus on value?Cancer 2014: Why do we need a focus on value?
Cancer 2014: Why do we need a focus on value?
 
Panel on Access
Panel on AccessPanel on Access
Panel on Access
 
Outcome Measures in Cancer: Do disease specific instruments offer greater sen...
Outcome Measures in Cancer: Do disease specific instruments offer greater sen...Outcome Measures in Cancer: Do disease specific instruments offer greater sen...
Outcome Measures in Cancer: Do disease specific instruments offer greater sen...
 
2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails2014 Berlin_ Operational Excellence in Clinical Trails
2014 Berlin_ Operational Excellence in Clinical Trails
 
Roadmap Molecular Diagnostics
Roadmap Molecular DiagnosticsRoadmap Molecular Diagnostics
Roadmap Molecular Diagnostics
 
Νικόλαος Τσούλος, MedTech Conference 2021
Νικόλαος Τσούλος, MedTech Conference 2021Νικόλαος Τσούλος, MedTech Conference 2021
Νικόλαος Τσούλος, MedTech Conference 2021
 
Asian Fund for Cancer Research Overview
Asian Fund for Cancer Research OverviewAsian Fund for Cancer Research Overview
Asian Fund for Cancer Research Overview
 
Making Value-Based Healthcare in Cataract a Reality Insights from VBHCAT Pr...
Making Value-Based Healthcare in Cataract a Reality  Insights from VBHCAT  Pr...Making Value-Based Healthcare in Cataract a Reality  Insights from VBHCAT  Pr...
Making Value-Based Healthcare in Cataract a Reality Insights from VBHCAT Pr...
 
Designing and implementing pathways to benefit patient aftercare: Continuing ...
Designing and implementing pathways to benefit patient aftercare: Continuing ...Designing and implementing pathways to benefit patient aftercare: Continuing ...
Designing and implementing pathways to benefit patient aftercare: Continuing ...
 
Investor & Analyst Day 2015: Cologuard Expansion (2/8)
Investor & Analyst Day 2015: Cologuard Expansion (2/8)Investor & Analyst Day 2015: Cologuard Expansion (2/8)
Investor & Analyst Day 2015: Cologuard Expansion (2/8)
 
SMi Group's 4th annual Orphan Drugs 2015 conference
SMi Group's 4th annual Orphan Drugs 2015 conferenceSMi Group's 4th annual Orphan Drugs 2015 conference
SMi Group's 4th annual Orphan Drugs 2015 conference
 
2474
24742474
2474
 
Efficiency Awards Winners Brochure 2011
Efficiency Awards Winners Brochure 2011Efficiency Awards Winners Brochure 2011
Efficiency Awards Winners Brochure 2011
 
Topic 1 a papers i foresight training pavia 2008 (1)
Topic 1 a papers i foresight training pavia 2008 (1)Topic 1 a papers i foresight training pavia 2008 (1)
Topic 1 a papers i foresight training pavia 2008 (1)
 
Next Generation Dx Summit 2015 - Moving Assays to the Clinic
Next Generation Dx Summit 2015 - Moving Assays to the ClinicNext Generation Dx Summit 2015 - Moving Assays to the Clinic
Next Generation Dx Summit 2015 - Moving Assays to the Clinic
 
CURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumCURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM Symposium
 
Personal Genomics: Business Model for 23andMe
Personal Genomics: Business Model for 23andMePersonal Genomics: Business Model for 23andMe
Personal Genomics: Business Model for 23andMe
 

Ähnlich wie SMi Group's 6th annual BioBanking 2016 conference

BioBanking 2017
BioBanking 2017BioBanking 2017
BioBanking 2017Teri Arri
 
SMi Groups' 4th annual BioBanking conference
SMi Groups' 4th annual BioBanking conferenceSMi Groups' 4th annual BioBanking conference
SMi Groups' 4th annual BioBanking conferenceDale Butler
 
SMi Group's BioBanking 2018
SMi Group's BioBanking 2018SMi Group's BioBanking 2018
SMi Group's BioBanking 2018Dale Butler
 
SMi Group's 9th annual Biobanking 2019 conference
SMi Group's 9th annual Biobanking 2019 conferenceSMi Group's 9th annual Biobanking 2019 conference
SMi Group's 9th annual Biobanking 2019 conferenceDale Butler
 
Biobanking 2010 Brochure
Biobanking 2010 BrochureBiobanking 2010 Brochure
Biobanking 2010 Brochurerohanshams
 
Biosample exchanges – the past, the current and the future – how do we make i...
Biosample exchanges – the past, the current and the future – how do we make i...Biosample exchanges – the past, the current and the future – how do we make i...
Biosample exchanges – the past, the current and the future – how do we make i...Pistoia Alliance
 
Bioprocessing of Advanced Cellular Therapies Congress
Bioprocessing of Advanced Cellular Therapies CongressBioprocessing of Advanced Cellular Therapies Congress
Bioprocessing of Advanced Cellular Therapies CongressTony Couch
 
SMi Group's 7th annual Biosimilars Europe 2016 conference
SMi Group's 7th annual Biosimilars Europe 2016 conferenceSMi Group's 7th annual Biosimilars Europe 2016 conference
SMi Group's 7th annual Biosimilars Europe 2016 conferenceDale Butler
 
Derick Mitchell_Biobanking from the patient perspective.pdf
Derick Mitchell_Biobanking from the patient perspective.pdfDerick Mitchell_Biobanking from the patient perspective.pdf
Derick Mitchell_Biobanking from the patient perspective.pdfipposi
 
P-155 Advances in Cell Based Assays
P-155 Advances in Cell Based AssaysP-155 Advances in Cell Based Assays
P-155 Advances in Cell Based AssaysWarka Ghirmai
 
SMi Group's 8th annual Advances in Cell Based Assays
SMi Group's 8th annual Advances in Cell Based AssaysSMi Group's 8th annual Advances in Cell Based Assays
SMi Group's 8th annual Advances in Cell Based AssaysDale Butler
 
P 151 biosimilars & biobetters
P 151 biosimilars & biobettersP 151 biosimilars & biobetters
P 151 biosimilars & biobettersDale Butler
 
SMi Group's Biosimilars 2019 conference
SMi Group's Biosimilars 2019 conferenceSMi Group's Biosimilars 2019 conference
SMi Group's Biosimilars 2019 conferenceDale Butler
 
SMi Group's Biosimilars & Biobetters conference
SMi Group's Biosimilars & Biobetters conference SMi Group's Biosimilars & Biobetters conference
SMi Group's Biosimilars & Biobetters conference Dale Butler
 
SMi Group's 11th annual Point of Care Diagnostics conference
SMi Group's 11th annual Point of Care Diagnostics conferenceSMi Group's 11th annual Point of Care Diagnostics conference
SMi Group's 11th annual Point of Care Diagnostics conferenceDale Butler
 
Bact agenda 2017 Tony
Bact agenda 2017 TonyBact agenda 2017 Tony
Bact agenda 2017 TonyTony Couch
 
Bio dinner presentation 2016 plus about one nucleus
Bio dinner presentation 2016 plus about one nucleusBio dinner presentation 2016 plus about one nucleus
Bio dinner presentation 2016 plus about one nucleusTony Jones
 
SMi Group's 2nd annual 3D Cell Culture 2018 conference
SMi Group's 2nd annual 3D Cell Culture 2018 conferenceSMi Group's 2nd annual 3D Cell Culture 2018 conference
SMi Group's 2nd annual 3D Cell Culture 2018 conferenceDale Butler
 
P-139_ADC Summit
P-139_ADC SummitP-139_ADC Summit
P-139_ADC SummitJames Bell
 
P-131_Superbugs and Superdrugs
P-131_Superbugs and SuperdrugsP-131_Superbugs and Superdrugs
P-131_Superbugs and SuperdrugsJames Bell
 

Ähnlich wie SMi Group's 6th annual BioBanking 2016 conference (20)

BioBanking 2017
BioBanking 2017BioBanking 2017
BioBanking 2017
 
SMi Groups' 4th annual BioBanking conference
SMi Groups' 4th annual BioBanking conferenceSMi Groups' 4th annual BioBanking conference
SMi Groups' 4th annual BioBanking conference
 
SMi Group's BioBanking 2018
SMi Group's BioBanking 2018SMi Group's BioBanking 2018
SMi Group's BioBanking 2018
 
SMi Group's 9th annual Biobanking 2019 conference
SMi Group's 9th annual Biobanking 2019 conferenceSMi Group's 9th annual Biobanking 2019 conference
SMi Group's 9th annual Biobanking 2019 conference
 
Biobanking 2010 Brochure
Biobanking 2010 BrochureBiobanking 2010 Brochure
Biobanking 2010 Brochure
 
Biosample exchanges – the past, the current and the future – how do we make i...
Biosample exchanges – the past, the current and the future – how do we make i...Biosample exchanges – the past, the current and the future – how do we make i...
Biosample exchanges – the past, the current and the future – how do we make i...
 
Bioprocessing of Advanced Cellular Therapies Congress
Bioprocessing of Advanced Cellular Therapies CongressBioprocessing of Advanced Cellular Therapies Congress
Bioprocessing of Advanced Cellular Therapies Congress
 
SMi Group's 7th annual Biosimilars Europe 2016 conference
SMi Group's 7th annual Biosimilars Europe 2016 conferenceSMi Group's 7th annual Biosimilars Europe 2016 conference
SMi Group's 7th annual Biosimilars Europe 2016 conference
 
Derick Mitchell_Biobanking from the patient perspective.pdf
Derick Mitchell_Biobanking from the patient perspective.pdfDerick Mitchell_Biobanking from the patient perspective.pdf
Derick Mitchell_Biobanking from the patient perspective.pdf
 
P-155 Advances in Cell Based Assays
P-155 Advances in Cell Based AssaysP-155 Advances in Cell Based Assays
P-155 Advances in Cell Based Assays
 
SMi Group's 8th annual Advances in Cell Based Assays
SMi Group's 8th annual Advances in Cell Based AssaysSMi Group's 8th annual Advances in Cell Based Assays
SMi Group's 8th annual Advances in Cell Based Assays
 
P 151 biosimilars & biobetters
P 151 biosimilars & biobettersP 151 biosimilars & biobetters
P 151 biosimilars & biobetters
 
SMi Group's Biosimilars 2019 conference
SMi Group's Biosimilars 2019 conferenceSMi Group's Biosimilars 2019 conference
SMi Group's Biosimilars 2019 conference
 
SMi Group's Biosimilars & Biobetters conference
SMi Group's Biosimilars & Biobetters conference SMi Group's Biosimilars & Biobetters conference
SMi Group's Biosimilars & Biobetters conference
 
SMi Group's 11th annual Point of Care Diagnostics conference
SMi Group's 11th annual Point of Care Diagnostics conferenceSMi Group's 11th annual Point of Care Diagnostics conference
SMi Group's 11th annual Point of Care Diagnostics conference
 
Bact agenda 2017 Tony
Bact agenda 2017 TonyBact agenda 2017 Tony
Bact agenda 2017 Tony
 
Bio dinner presentation 2016 plus about one nucleus
Bio dinner presentation 2016 plus about one nucleusBio dinner presentation 2016 plus about one nucleus
Bio dinner presentation 2016 plus about one nucleus
 
SMi Group's 2nd annual 3D Cell Culture 2018 conference
SMi Group's 2nd annual 3D Cell Culture 2018 conferenceSMi Group's 2nd annual 3D Cell Culture 2018 conference
SMi Group's 2nd annual 3D Cell Culture 2018 conference
 
P-139_ADC Summit
P-139_ADC SummitP-139_ADC Summit
P-139_ADC Summit
 
P-131_Superbugs and Superdrugs
P-131_Superbugs and SuperdrugsP-131_Superbugs and Superdrugs
P-131_Superbugs and Superdrugs
 

Mehr von Dale Butler

SMi Group's Pharmaceutical Microbiology West Coast 2020 conference
SMi Group's Pharmaceutical Microbiology West Coast 2020 conferenceSMi Group's Pharmaceutical Microbiology West Coast 2020 conference
SMi Group's Pharmaceutical Microbiology West Coast 2020 conferenceDale Butler
 
SMi Group's Pre-filled Syringes West Coast 2020 conference
SMi Group's Pre-filled Syringes West Coast 2020 conferenceSMi Group's Pre-filled Syringes West Coast 2020 conference
SMi Group's Pre-filled Syringes West Coast 2020 conferenceDale Butler
 
SMi Group's Future Armoured Vehicles Protection Systems USA 2020 conference
SMi Group's Future Armoured Vehicles Protection Systems USA 2020 conferenceSMi Group's Future Armoured Vehicles Protection Systems USA 2020 conference
SMi Group's Future Armoured Vehicles Protection Systems USA 2020 conferenceDale Butler
 
SMi Group's Military Robotics and Autonomous Systems USA 2020 conference
SMi Group's Military Robotics and Autonomous Systems USA 2020 conferenceSMi Group's Military Robotics and Autonomous Systems USA 2020 conference
SMi Group's Military Robotics and Autonomous Systems USA 2020 conferenceDale Butler
 
SMi Group's Future Soldier Technology USA 2020 conference
SMi Group's  Future Soldier Technology USA 2020 conferenceSMi Group's  Future Soldier Technology USA 2020 conference
SMi Group's Future Soldier Technology USA 2020 conferenceDale Butler
 
SMi Group's Military Space USA 2020 conference
SMi Group's Military Space USA 2020 conferenceSMi Group's Military Space USA 2020 conference
SMi Group's Military Space USA 2020 conferenceDale Butler
 
SMi Group's Helicopter Technology CEE 2020 conference
SMi Group's Helicopter Technology CEE 2020 conferenceSMi Group's Helicopter Technology CEE 2020 conference
SMi Group's Helicopter Technology CEE 2020 conferenceDale Butler
 
SMi Group's Future Armoured Vehicles CEE 2020 conference
SMi Group's Future Armoured Vehicles CEE 2020 conferenceSMi Group's Future Armoured Vehicles CEE 2020 conference
SMi Group's Future Armoured Vehicles CEE 2020 conferenceDale Butler
 
SMi Group's Unmanned Maritime Systems 2020 conference
SMi Group's Unmanned Maritime Systems 2020 conferenceSMi Group's Unmanned Maritime Systems 2020 conference
SMi Group's Unmanned Maritime Systems 2020 conferenceDale Butler
 
SMi Group's Military PNT 2020 conference
SMi Group's Military PNT 2020 conferenceSMi Group's Military PNT 2020 conference
SMi Group's Military PNT 2020 conferenceDale Butler
 
SMi Group's Defence Aviation Safety 2020
SMi Group's Defence Aviation Safety 2020SMi Group's Defence Aviation Safety 2020
SMi Group's Defence Aviation Safety 2020Dale Butler
 
SMi Group's Pre-filled Syringes East Coast 2020
SMi Group's Pre-filled Syringes East Coast 2020 SMi Group's Pre-filled Syringes East Coast 2020
SMi Group's Pre-filled Syringes East Coast 2020 Dale Butler
 
SMi Group's Air Mission Planning and Support 2020
SMi Group's Air Mission Planning and Support 2020SMi Group's Air Mission Planning and Support 2020
SMi Group's Air Mission Planning and Support 2020Dale Butler
 
SMi Group's Future Armoured Vehicles Situational Awareness 2020
SMi Group's Future Armoured Vehicles Situational Awareness 2020 SMi Group's Future Armoured Vehicles Situational Awareness 2020
SMi Group's Future Armoured Vehicles Situational Awareness 2020 Dale Butler
 
SMi Group's Military Robotics and Autonomous Systems 2020
SMi Group's Military Robotics and Autonomous Systems 2020 SMi Group's Military Robotics and Autonomous Systems 2020
SMi Group's Military Robotics and Autonomous Systems 2020 Dale Butler
 
SMi Group's Future Soldier Technology 2020 conference
SMi Group's Future Soldier Technology 2020 conferenceSMi Group's Future Soldier Technology 2020 conference
SMi Group's Future Soldier Technology 2020 conferenceDale Butler
 
SMi Group's Defence Logistics CEE 2020
SMi Group's Defence Logistics CEE 2020SMi Group's Defence Logistics CEE 2020
SMi Group's Defence Logistics CEE 2020Dale Butler
 
SMi Group's Superbugs and Superdrugs 2020 conference
SMi Group's Superbugs and Superdrugs 2020 conferenceSMi Group's Superbugs and Superdrugs 2020 conference
SMi Group's Superbugs and Superdrugs 2020 conferenceDale Butler
 
SMi Group's AI in Drug Discovery 2020 conference
SMi Group's AI in Drug Discovery 2020 conferenceSMi Group's AI in Drug Discovery 2020 conference
SMi Group's AI in Drug Discovery 2020 conferenceDale Butler
 

Mehr von Dale Butler (20)

SMi Group's Pharmaceutical Microbiology West Coast 2020 conference
SMi Group's Pharmaceutical Microbiology West Coast 2020 conferenceSMi Group's Pharmaceutical Microbiology West Coast 2020 conference
SMi Group's Pharmaceutical Microbiology West Coast 2020 conference
 
SMi Group's Pre-filled Syringes West Coast 2020 conference
SMi Group's Pre-filled Syringes West Coast 2020 conferenceSMi Group's Pre-filled Syringes West Coast 2020 conference
SMi Group's Pre-filled Syringes West Coast 2020 conference
 
SMi Group's Future Armoured Vehicles Protection Systems USA 2020 conference
SMi Group's Future Armoured Vehicles Protection Systems USA 2020 conferenceSMi Group's Future Armoured Vehicles Protection Systems USA 2020 conference
SMi Group's Future Armoured Vehicles Protection Systems USA 2020 conference
 
SMi Group's Military Robotics and Autonomous Systems USA 2020 conference
SMi Group's Military Robotics and Autonomous Systems USA 2020 conferenceSMi Group's Military Robotics and Autonomous Systems USA 2020 conference
SMi Group's Military Robotics and Autonomous Systems USA 2020 conference
 
SMi Group's Future Soldier Technology USA 2020 conference
SMi Group's  Future Soldier Technology USA 2020 conferenceSMi Group's  Future Soldier Technology USA 2020 conference
SMi Group's Future Soldier Technology USA 2020 conference
 
SMi Group's Military Space USA 2020 conference
SMi Group's Military Space USA 2020 conferenceSMi Group's Military Space USA 2020 conference
SMi Group's Military Space USA 2020 conference
 
SMi Group's Helicopter Technology CEE 2020 conference
SMi Group's Helicopter Technology CEE 2020 conferenceSMi Group's Helicopter Technology CEE 2020 conference
SMi Group's Helicopter Technology CEE 2020 conference
 
SMi Group's Future Armoured Vehicles CEE 2020 conference
SMi Group's Future Armoured Vehicles CEE 2020 conferenceSMi Group's Future Armoured Vehicles CEE 2020 conference
SMi Group's Future Armoured Vehicles CEE 2020 conference
 
SMi Group's Unmanned Maritime Systems 2020 conference
SMi Group's Unmanned Maritime Systems 2020 conferenceSMi Group's Unmanned Maritime Systems 2020 conference
SMi Group's Unmanned Maritime Systems 2020 conference
 
SMi Group's Military PNT 2020 conference
SMi Group's Military PNT 2020 conferenceSMi Group's Military PNT 2020 conference
SMi Group's Military PNT 2020 conference
 
SMi Group's Defence Aviation Safety 2020
SMi Group's Defence Aviation Safety 2020SMi Group's Defence Aviation Safety 2020
SMi Group's Defence Aviation Safety 2020
 
SMi Group's Pre-filled Syringes East Coast 2020
SMi Group's Pre-filled Syringes East Coast 2020 SMi Group's Pre-filled Syringes East Coast 2020
SMi Group's Pre-filled Syringes East Coast 2020
 
SMi Group's Air Mission Planning and Support 2020
SMi Group's Air Mission Planning and Support 2020SMi Group's Air Mission Planning and Support 2020
SMi Group's Air Mission Planning and Support 2020
 
SMi Group's Future Armoured Vehicles Situational Awareness 2020
SMi Group's Future Armoured Vehicles Situational Awareness 2020 SMi Group's Future Armoured Vehicles Situational Awareness 2020
SMi Group's Future Armoured Vehicles Situational Awareness 2020
 
SMi Group's Military Robotics and Autonomous Systems 2020
SMi Group's Military Robotics and Autonomous Systems 2020 SMi Group's Military Robotics and Autonomous Systems 2020
SMi Group's Military Robotics and Autonomous Systems 2020
 
SMi Group's Future Soldier Technology 2020 conference
SMi Group's Future Soldier Technology 2020 conferenceSMi Group's Future Soldier Technology 2020 conference
SMi Group's Future Soldier Technology 2020 conference
 
SMi Group's Defence Logistics CEE 2020
SMi Group's Defence Logistics CEE 2020SMi Group's Defence Logistics CEE 2020
SMi Group's Defence Logistics CEE 2020
 
Space Week 2020
Space Week 2020Space Week 2020
Space Week 2020
 
SMi Group's Superbugs and Superdrugs 2020 conference
SMi Group's Superbugs and Superdrugs 2020 conferenceSMi Group's Superbugs and Superdrugs 2020 conference
SMi Group's Superbugs and Superdrugs 2020 conference
 
SMi Group's AI in Drug Discovery 2020 conference
SMi Group's AI in Drug Discovery 2020 conferenceSMi Group's AI in Drug Discovery 2020 conference
SMi Group's AI in Drug Discovery 2020 conference
 

Kürzlich hochgeladen

4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfPatidar M
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Projectjordimapav
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
EMBODO Lesson Plan Grade 9 Law of Sines.docx
EMBODO Lesson Plan Grade 9 Law of Sines.docxEMBODO Lesson Plan Grade 9 Law of Sines.docx
EMBODO Lesson Plan Grade 9 Law of Sines.docxElton John Embodo
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management systemChristalin Nelson
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataBabyAnnMotar
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptshraddhaparab530
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operationalssuser3e220a
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSMae Pangan
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxlancelewisportillo
 
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...JojoEDelaCruz
 

Kürzlich hochgeladen (20)

4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdf
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Project
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
EMBODO Lesson Plan Grade 9 Law of Sines.docx
EMBODO Lesson Plan Grade 9 Law of Sines.docxEMBODO Lesson Plan Grade 9 Law of Sines.docx
EMBODO Lesson Plan Grade 9 Law of Sines.docx
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management system
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped data
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.ppt
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operational
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHS
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
 
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
 

SMi Group's 6th annual BioBanking 2016 conference

  • 1. www.bio-banking-event.com Register online or fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711 @SMIPHARM #BioBankingSMi CHAIRS: • Emma Snapes, Biobank Manager, Infant Biobank • Dr Brian Thomson, Director and Clinical Lead for 100K Genome Project, Nottingham Health Science Biobank KEYNOTE SPEAKERS INCLUDE: • Professor Glyn Stacey, Director, UK Stem Cell Bank, Division of Advanced Therapies, National Institute for Biological Standards and Control - MHRA • Octavi Quintana Trias, Principal Advisor of DG, European Commission • Dr Julia Riedlinger, Head of Marker Scouting and Sample Bank, Roche Diagnostics • Arthur Lewis, Senior R&D Manager, MedImmune • Dr Michael Luntang-Jensen, Biobank Manager, H. Lundbeck A/S • Jonathan Sellors, Legal Counsel, UK Biobank BENEFITS OF ATTENDING IN 2016: • Spotlight session - Creating a biobank for drug discovery • Hear the latest updates on Data Protection Act from European Commission and UK Biobank • Learn about the integration of biobanking in drug development • Obtain an overview of how to build and design a model of next generation biobank • Discover the latest updates on biobanking in the 21st Century 20TH-21ST JUNE 2016HOLIDAY INN KENSINGTON FORUM, LONDON, UK SMi presents the 6th annual… BioBankingEnsuring compliance through regulatory updates and its impact on biobanking BOOK BY 31ST MARCH TO SAVE £400 • BOOK BY 29TH APRIL TO SAVE £300 • BOOK BY 27TH MAY 2016 AND SAVE £200 HEAR FROM MHRA, EUROPEAN COMMISSION PLUS LEADING EUROPEAN BIOBANKS!
  • 2. BioBanking Day One | 20th June 2016 www.bio-banking-event.com 8.30 Registration & Coffee 9.00 Chairman’s Opening Remarks Emma Snapes, Biobank Manager, Infant Biobank OPENING ADDRESS 9.10 Biobanking in the 21st century: Where are we now? • Public engagement • Ethics and regulatory issues • Sustainability • Harmonisation Emma Snapes, Biobank Manager, Infant Biobank KEYNOTE ADDRESS 9.50 Assuring long term supply chain of stem cells for future therapies • The key issues relating to the cryo-conservation of stem cell cultures of human pluripotent stem cell lines are significant loss of viable cells during preservation and recovery, reproducibility and reliability of recovery from preservation and assuring appropriate storage quarantine procedures • Establishing appropriate systems to ensure stable storage temperatures and suitable testing regimes for viability and recovery testing regimes are essential for operation of successful stem cell biobanks • Requalification of stem cell banks over the long term will need to be considered, based on developing scientific knowledge and emerging issues Prof Glyn Stacey, Director, UK Stem Cell Bank, Division of Advanced Therapies, National Institute for Biological Standards and Control – MHRA 10.30 Morning Coffee BIOBANKING AS A BUSINESS 11.00 Auria Biobank – model for next generation biobanking • What does next generation biobanking mean? • Gain insight to the rewards of innovative biobanking • Sustainability by Public-Private Partnership and new co-operation models Heli Salminen-Mankonen, Director, Auria Biobank 11.40 Designing a modern biobank • Formation of a biobank • Ethical and legal issues • Developing a sustainable business model • Personalised medicine vs general medicine • Maximising value thought publicity Dr. Balwir Matharoo-Ball, Deputy Director of Nottingham Health Science Biobank, Nottingham University Hospital NHS Trust 12.20 Networking Lunch THE POWER OF SAMPLES 1.30 Biomarker identification and validation – the crucial role of samples • Challenges of biomarker discovery and validation • Access to well-characterised samples • Sample and data quality • Ethical considerations Dr Julia Riedlinger, Head of Marker Scouting and Sample Bank, Roche Diagnostics 2.10 Optimising clinical laboratory sample usage • Focus on Science to maximise the use of every sample • Adapt to legislation changes • Optimising sample collection and analysis Dr Catherine Mela, Director Clinical Sample Science, AstraZeneca 2.50 Afternoon Tea 3.20 Human tissue driving biologics research • Why is human tissue important - selecting relevant therapeutic targets • How is human tissue used for and how can bio banks work with biopharma • What is human tissue delivering to biologics research Dr Arthur Lewis, Senior R&D Manager, MedImmune 4.00 Impact of brain bio-banking on Parkinson’s disease research • Shedding light on disease mechanisms • Identification of drug targets • Neuropathological confirmation of clinical diagnosis Prof David Dexter, Director of Parkinson’s UK Tissue Bank, Imperial College London 4.40 Chairman’s Closing Remarks and Close of Day One Register online at www.bio-banking-event.com SUPPORTED BY SPONSORSHIP AND EXHIBITION OPPORTUNITIES SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to complement your company’s marketing strategy. Prime networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your industry. Should you wish to join the increasing number of companies benefiting from sponsoring our conferences please call: Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk OFFICIAL MEDIA PARTNERS OFFICIAL PUBLICATIONS
  • 3. BioBanking www.bio-banking-event.com Day Two | 21st June 2016 8.30 Registration & Coffee 9.00 Chairman’s Opening Remarks Dr Brian Thomson, Director and Clinical Lead for 100K Genome Project, Nottingham Health Science Biobank ETHICAL AND REGULATORY LANDSCAPE KEYNOTE OPENING ADDRESS 9.10 Data Protection Act • Revision of the latest changes • The effect on local projects • Ethical dilemma when sharing biobank data • Regulation and sustainability of biobanking in general Octavi Quintana Trias, Principal Advisor of DG, European Commission 9.50 Use of research data • The use of pseudo-anonymised participant data in research, and common misunderstandings relating to such use in the application of the law on data protection and confidentiality • Linkage between research data sets – common problems (and misunderstandings) • The prevailing legal framework in the UK and how this will be impacted by the EU Data Protection Regulation Jonathan Sellors, Legal Counsel, UK Biobank 10.30 Morning Coffee HARMONISATION IN BIOBANKING 11.00 European Bank for induced Pluripotent Stem Cells (EBiSC): Creating a biobank for stem cells • Why induced Pluripotent Stem Cells (iPSCs) represent an important new research tool • How the (EBiSC) acts as a central repository for iPSC lines created across Europe • The challenges encountered in building the bank Aidan Courtney, Chief Executive Officer, Roslin Cell Sciences Ltd 11.40 European Bank for induced Pluripotent Stem Cells (EBiSC): International distribution and long-term sustainability • Challenges of international distribution of cell lines • Creating and satisfying end user demand • Factors influencing long-term sustainability of biobanks Dr Bryan Bolton, Head of Business Development, Culture Collection, Public Health England 12.20 Networking Lunch 1.30 Biobanking and genomic research in clinical trials: Challenges and solutions in working with global health authorities and IRB/IECs • Discuss Merck’s clinical pharmacogenomic and biobanking strategy • Understand challenges in biobanking and conducting genomic research in the context of global clinical trials • Discuss strategies and solutions to manage requirements from global health authorities and IRB/IECs Dr Karina Bienfait, Head, Global Genomics Policy, Process and Compliance, MSD 2.10 Integration of biobanking in drug development • Organizational and logistic requirements for high quality sample management • Ethical and regulatory challenges • Management responsibility and governance Dr Michael Luntang-Jensen, Biobank Manager, H. Lundbeck A/S 2.50 Afternoon Tea 3.20 Creating a UK biobanking network; the human and technological challenges • Biobanking in the UK - the need for transformation • Realising the value of biobanks as platforms for precision medicine • The purpose of the UKCRC Directory • How the Directory fits into the European programme • The future - standardisation Dr Brian Thomson, Director and Clinical Lead for 100K Genome Project, Nottingham Health Science Biobank Dr Phil Quinlan, Interim Director, UKCRC Tissue Directory and Co-ordination Centre, University of Nottingham 4.00 The CCLG tissue bank: Experience from a national children’s tumour bank Dr Thomas Jacques, Chair CCLG Biological Studies Steering Group, University College London 4.40 Chairman’s Closing Remarks and Close of Day Two Alternatively fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711 SUPPORTED BY Want to know how you can get involved? Interested in promoting your services to this market? Contact Honey de Gracia, SMi Marketing on +44 (0)20 7827 6102 or email: hdegracia@smi-online.co.uk SPOTLIGHT SESSION
  • 4. Benefits of Sponsoring Biobanking 2016 The industry has reached a tipping point and is about to enter the commercial stage. With lots of exciting opportunities ahead of biobanks, join our 6th annual Biobanking meeting to: 1. Showcase your biobanking services and products through keynote presentation to senior decision makers to help them overcome commercial challenges 2. Leverage your brand and exposure by exhibiting 3. Meet and network with senior decision makers – understand their priorities and how their businesses are developing 4. Engage with your prospects and foster growth with existing clients during our quality networking breaks 5. Ensure your service and product offerings fit with the industry’s today needs, and benefit from our tailored sponsorship packages For further information, please contact Alia Malick, Director, on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk Past Years’ Attendees Profile by Sector Register online at www.bio-banking-event.com Pharma & Biotech 59.5% Academia 16.2% Consultancy 13.5% Regulatory 10.8% 59.5% 13.5% 10.8% 16.2%
  • 5. SMi PHARMACEUTICAL EVENT PLANNER 2016 MARCH Superbugs & Superdrugs - A Focus on Antibacterials 16th - 17th March Holiday Inn Kensington Forum, London, UK Paediatric Clinical Trials 16th - 17th March Holiday Inn Kensington Forum, London, UK APRIL Asthma & COPD 11th - 12th April Holiday Inn Kensington Forum, London, UK Controlled Release 18th - 19th April Holiday Inn Kensington Forum, London, UK Adaptive Designs 18th - 19th April Holiday Inn Kensington Forum, London, UK Pre-Filled Syringes East Coast 25th - 26th April Renaissance Woodbridge, New Jersey, USA Lyophilization USA 27th - 28th April Renaissance Woodbridge, New Jersey, USA MAY Alzheimer’s 10th - 11th May Holiday Inn Kensington Forum, London, UK Clinical Trial Logistics 18th - 19th May Holiday Inn Kensington Forum, London, UK Pain Therapeutics 23rd - 24th May Holiday Inn Kensington Forum, London, UK ADC Summit 2016 23rd - 24th May Holiday Inn Kensington Forum, London, UK JUNE Pre-Filled Syringes West Coast 6th - 7th June Hyatt Regency Mission Bay, San Diego, USA ADMET 13th - 14th June Holiday Inn Kensington Forum, London, UK Immunogenicity 13th - 14th June Holiday Inn Kensington Forum, London, UK BioBanking 20th - 21st June Holiday Inn Kensington Forum, London, UK JULY Lyophilisation Europe 4th - 5th July Holiday Inn Kensington Forum, London, UK Allergies 6th - 7th July Holiday Inn Kensington Forum, London, UK Peptides 6th - 7th July Holiday Inn Kensington Forum, London, UK
  • 6. Please complete fully and clearly in capital letters. Please photocopy for additional delegates. Title: Forename: Surname: Job Title: Department/Division: Company/Organisation: Email: Company VAT Number: Address: Town/City: Post/Zip Code: Country: Direct Tel: Direct Fax: Mobile: Switchboard: Signature: Date: I agree to be bound by SMi’s Terms and Conditions of Booking. ACCOUNTS DEPT Title: Forename: Surname: Email: Address (if different from above): Town/City: Post/Zip Code: Country: Direct Tel: Direct Fax: BIOBANKING Conference: 20th - 21st June 2016, Holiday Inn Kensington Forum, London, UK 4 WAYS TO REGISTER FAX your booking form to +44 (0) 870 9090 712 PHONE on +44 (0) 870 9090 711 ONLINE at www.bio-banking-event.com POST your booking form to: Events Team, SMi Group Ltd, 2nd Floor South, Harling House, 47-51 Great Suffolk Street, London, SE1 0BS If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email them at events@smi-online.co.uk Payment: If payment is not made at the time of booking, then an invoice will be issued and must be paid immediately and prior to the start of the event. If payment has not been received then credit card details will be requested and payment taken before entry to the event. Bookings within 7 days of event require payment on booking. Access to the Document Portal will not be given until payment has been received. Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another delegate to take your place at any time prior to the start of the event. Two or more delegates may not ‘share’ a place at an event. Please make separate bookings for each delegate. Cancellation: If you wish to cancel your attendance at an event and you are unable to send a substitute, then we will refund/credit 50% of the due fee less a £50 administration charge, providing that cancellation is made in writing and received at least 28 days prior to the start of the event. Regretfully cancellation after this time cannot be accepted. We will however provide the conferences documentation via the Document Portal to any delegate who has paid but is unable to attend for any reason. Due to the interactive nature of the Briefings we are not normally able to provide documentation in these circumstances. We cannot accept cancellations of orders placed for Documentation or the Document Portal as these are reproduced specifically to order. If we have to cancel the event for any reason, then we will make a full refund immediately, but disclaim any further liability. Alterations: It may become necessary for us to make alterations to the content, speakers, timing, venue or date of the event compared to the advertised programme. Data Protection: The SMi Group gathers personal data in accordance with the UK Data Protection Act 1998 and we may use this to contact you by telephone, fax, post or email to tell you about other products and services. Unless you tick here □ we may also share your data with third parties offering complementary products or services. If you have any queries or want to update any of the data that we hold then please contact our Database Manager databasemanager@smi-online. co.uk or visit our website www.smi-online.co.uk/updates quoting the URN as detailed above your address on the attached letter. Unique Reference Number Our Reference P-174 Terms and Conditions of Booking DELEGATE DETAILS Payment must be made to SMi Group Ltd, and received before the event, by one of the following methods quoting reference P-174 and the delegate’s name. Bookings made within 7 days of the event require payment on booking, methods of payment are below. Please indicate method of payment: □ UK BACS Sort Code 300009, Account 00936418 □ Wire Transfer Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AU Swift (BIC): LOYDGB21013, Account 00936418 IBAN GB48 LOYD 3000 0900 9364 18 □ Cheque We can only accept Sterling cheques drawn on a UK bank. □ Credit Card □ Visa □ MasterCard □ American Express All credit card payments will be subject to standard credit card charges. Card No: □□□□ □□□□ □□□□ □□□□ Valid From □□/□□ Expiry Date □□/□□ CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card Cardholder’s Name: Signature: Date: I agree to be bound by SMi’s Terms and Conditions of Booking. Card Billing Address (If different from above): DOCUMENTATION I cannot attend but would like to Purchase access to the following Document Portal/ Paper Copy documentation. Price Total □ Access to the conference documentation on the Document Portal £499.00 + VAT £598.80 □ The Conference Presentations – paper copy £499.00 - £499.00 (or only £300 if ordered with the Document Portal) PAYMENT VAT VAT at 20% is charged on the attendance fees for all delegates. VAT is also charged on Document portal and literature distribution for all UK customers and for those EU Customers not supplying a registration number for their own country here CONFERENCE PRICES GROUP DISCOUNTS AVAILABLE I would like to attend: (Please tick as appropriate) Fee TOTAL □ Conference £1499.00 + VAT £1798.80 PROMOTIONAL LITERATURE DISTRIBUTION □ Distribution of your company’s promotional literature to all conference attendees £999.00 + VAT £1198.80 The conference fee includes refreshments, lunch, conference papers, and access to the Document Portal. Presentations that are available for download will be subject to distribution rights by speakers. Please note that some presentations may not be available for download. Access information for the document portal will be sent to the e-mail address provided during registration. Details are sent within 24 hours post conference. VENUE Holiday Inn Kensington Forum, 97 Cromwell Road, London SW7 4DN □ Please contact me to book my hotel Alternatively call us on +44 (0) 870 9090 711, email: events@smi-online.co.uk or fax +44 (0) 870 9090 712 □ Book by 31st March 2016 and save £400 □ Book by 29th April 2016 and save £300 □ Book by 27th May 2016 and save £200 EARLY BIRD DISCOUNT